fosmetpantotenate (RE-024)

fosmetpantotenate · Travere Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for fosmetpantotenate (RE-024), covering 2020-12-29 to 2020-12-29. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety Study of Fosmetpantotenate (RE-024) in PKAN Participants [Phase 3]